Arlington, VA. May 28, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO in in response to the Notice of Proposed Rulemaking on the Setting and Adjusting Trademark Fees During Fiscal Year 2025.

Arlington, VA. May 21, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO in response to the Notice of Proposed Rulemaking on Expanding Opportunities to Appear Before the Patent Trial and Appeal Board (PTAB).

Arlington, VA. May 10, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO in response to the recently-published Inventorship Guidance for AI-Assisted Inventions.

Arlington, VA. May 14, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the USPTO’s Request for Comment regarding Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace.

Arlington, VA. May 10, 2024 - The American Intellectual Property Law Association (AIPLA) filed an amicus brief in support of neither party with the Court of Appeals for the Federal Circuit in REGENXBIO Inc. v. Sarepta Therapeutics, Inc., a case on appeal from the U.S. District Court for the District of Delaware. The district court held that cultured host cells containing a recombinant nucleic acid molecule were not eligible for patent protection under Section 101 of the Patent Act because the individual nucleic acid sequences used in the recombinant molecule were not modified or changed from their naturally occurring state.